Search

everythinglearnresearchcommunity

for

Search:↓

No true link between AGA and insulin resistance, but coexistence may worsen AGA.

AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.

Platelet-Rich Plasma (PRP), a substance from a patient's own blood, can stimulate hair regrowth in people with Androgenetic Alopecia (AGA) who haven't had success with other treatments, but more research is needed to optimize its use.

AGA affects many, progresses differently, and early treatment is crucial.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

AGA linked to inflammation, stress, fibrosis, and disturbed hair follicle stem cells.

AGA in children needs careful diagnosis due to low androgen levels and possible other causes.

Higher cell number PRP improves hair density and diameter more than lower cell number PRP.

SA linked to mitochondrial issues and oxidative stress, while AGA involves disrupted hair growth genes.

New method, hair distribution width (HDW), improves accuracy in diagnosing androgenetic alopecia (AGA).

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

AGA is a common hair loss disorder, and early diagnosis and treatment with minoxidil or finasteride can help reduce emotional distress.

New regenerative therapies show promise for treating hair loss.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.

New treatment effectively reverses hair thinning in most patients with mild side effects.

AGA causes permanent hair loss; women use 2% minoxidil, men use 1 mg finasteride daily.

AGA causes permanent hair loss; minoxidil helps men, finasteride helps men, minoxidil somewhat helps women, estrogens/antiandrogens lack evidence for women.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

Darker hair colors may increase the risk of alopecia areata, while lighter hair colors may decrease it.

Smoking increases the risk of hair loss, especially male pattern baldness.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

The visfatin GT genotype may increase the risk of Alopecia Areata.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

People with alopecia have a higher risk of thyroid cancer.